News

MEI Pharma’s $100M Litecoin purchase fuels a 100% stock surge, marking a groundbreaking move in crypto treasury strategy.
In a bold move that’s redefining crypto’s relationship with traditional finance, MEI Pharma, a Nasdaq-listed company known ...
LTC gained more than 12% in the past 24 hours, following two major institutional announcements. First and foremost, Luxxfolio ...
MEI Pharma announces a $100 million private placement to adopt Litecoin as its primary treasury reserve asset.
MEI Pharma ( (MEIP)) has issued an update. On July 17, 2025, MEI Pharma entered into securities purchase agreements for a private placement offering, raising approximately $100 million to initiate a ...
Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging ...
MEI Pharma, Inc. (NASDAQ:MEIP) is one of the hot penny stocks to invest in now. On July 18, MEI Pharma, Inc. (NASDAQ:MEIP) ...
MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...
MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...
MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting ...
MEI Pharma and Infinity Pharmaceuticals will host a conference call and webcast today at 8:00 a.m. ET to discuss the merger. To access the live call, please dial 1-833-974-2378 (United States) or ...
MEI Pharma, Inc. (Nasdaq: MEIP) is a pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma’s portfolio of drug candidates includes clinical stage candidates with ...